Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis

<div><b>Forest plots of relative risk in CR rate.</b> (a) CR rate at week 4; (b) CR rate at month 3. CI: confidence interval; M-H: Mantel-Haenszel; RR: relative risk.</div>

BioMed Research International

fig3

Figure 3

Figure 3: Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis 

Figure 3 | Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis 